Treatment outcomes of AIDS-associated Kaposi's sarcoma under a routine antiretroviral therapy program in Lilongwe, Malawi: Bleomycin/vincristine compared to vincristine monotherapy

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Mwafongo, Albert A ^a   Rosenberg, Nora E ^a,b   Ng'ambi, Wingston ^c   Werner, Alexandra B ^b   Garneau, William M ^b   Gumulira, Joe ^c   Phiri, Sam ^c   Hosseinipour, Mina C ^a,b  

^a UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c LIGHTHOUSE TRUST   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; VINCRISTINE; ANTINEOPLASTIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; FEMALE; HUMAN; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALAWI; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; AIDS-RELATED OPPORTUNISTIC INFECTIONS; SARCOMA, KAPOSI;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTINEOPLASTIC AGENTS; BLEOMYCIN; FEMALE; HUMANS; MALAWI; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SARCOMA, KAPOSI; TREATMENT OUTCOME; VINCRISTINE;

EID: 84898439104     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091020     Document Type: Article

References (32)

1. Mosam A, Aboobake J, Shaik F (2010), Kaposi's sarcoma in sub-Saharan Africa: A Current Perspective. Current Opinion in Infectious Diseases, 23:119-123
2. Msyamboza KP, Dzamalala C, Mdokwe C, Kamiza S, Lemerani M, et al. (2012), Burden of cancer in Malawi; common types, incidence and trends: National population-based cancer registry. BMC Research Notes, 5:149.
3. Makombe S, Harries A, Kwong-Leung Yu J, Hochgesang M, Mhango E, et al. (2008), Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine program conditions in Malawi. Tropical Doctor; 38: 5-7
4. Dittmer D, Richards K, Damania B (2012) Treatment of Kaposi sarcoma associated herpesvirus-associated cancers. Frontiers in Microbiology, Volume 3.
5. Bihl F, Mosam A, Henry L, Chisholm J, Dollard S, et al. (2007)Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma. AIDS, 21:1245-1252. (Pubitemid 46883478)
6. Mlombe Y (2008) Management of HIV associated Kaposi's Sarcoma in Malawi, Malawi Medical Journal, 20(4), 129-132.
7. Mintzer D, Real FX, Jovino L, Krown S (1985)Treatment of Kaposi's Sarcoma and thrombocytopenia with Vincristine in patients with the Acquired Immunodeficiency Syndrome, Ann Intern Med.;102(2): 200-202. (Pubitemid 15157170)
8. Gill P, Rarick M, McCutchan JA, Slate L, Parker B, et al. (1991) Systemic treatment of AIDS related Kaposi's sarcoma: Results of a randomized trial, The American Journal of Medicine, April 1991, 90 (4), 427-433.
9. Gill PS, Rarick M, Espina B, Loureiro C, Bernstein-Singer M, et al. (1990) Advanced Acquired Immune Deficiency Syndrome-related Kaposi's Sarcoma: Results of pilot studies using combination chemotherapy, Cancer, 65, 1074-1078. (Pubitemid 20072036)
10. Vanni T, Fonseca B, Polanczyk C (2006) Cost-Effectiveness Analysis Comparing Chemotherapy Regimens in the Treatment of AIDS-Related Kaposi's Sarcoma in Brazil, HIV Clin Trials;7(4):194-202. (Pubitemid 44717783)
11. HIV unit (2003): Treatment of AIDS. Guidelines for the use of antiretroviral therapy in Malawi, Ministry of Health, Malawi.
12. Krown S, Metroka C, Wernz J (1989) Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria, Journal of Clinical Oncology, Vol. 7, No9: 1201-1207 (Pubitemid 19220121)
13. Krown SE (2004) Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: Implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma. J Clinical Oncol.; 22: 399-402.
14. Tweya H, Gareta D, Chagwera F, Ben-Smith A, Mwenyemasi J, et al. (2010) Early active follow-up of patients on antiretroviral therapy (ART) who are lost to follow-up: the 'Back-to-Care' project in Lilongwe, Malawi, Tropical Medicine and International Health, vol. 15 (1), 82-89.
15. Yu J, Chen S, Wang K, Chang C, Makombe S, et al. (2007) True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi, Bulletin of the World Health Organization 2007;85:550-554. (Pubitemid 47041634)
16. Weigel R, Hochgesang M, Brinkhof M, Hosseinipour M, Matt Boxshall M, et al. (2011) Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi, BMC Infectious Diseases, 11:31.
17. Gompels M, Hill A, Jenkins P, Peters B, Tomlison D, et al. (1992) Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin, AIDS: 6, 1175-80.
18. Gill P, Rarick M, Bernstein-Singer M (1990) Treatment of Advanced Kaposi's Sarcoma using a Combination of bleomycin and vincristine, Am J Clinical Oncology, 13 (4): 315-319. (Pubitemid 20262857)
19. Cottrill CP, Botomley DM, Phillips RH (1997) Cancer and HIV Infection, Clinical Oncology, 9, 365-380. (Pubitemid 28017840)
20. Francis H, Bates M, Kalilani L (2012) A Prospective study assessing tumour response, survival, and palliative care outcomes in patients with HIV-related Kaposi's Sarcoma at Queen Elizabeth Central Hospital, Blantyre, Malawi, AIDS Research and Treatment, Volume 2012.
21. Mintzer D, Real F, Jovino L, Krown S (1985)Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome, Ann Intern Med.;102(2):200-202 (Pubitemid 15157170)
22. Uldrick T, Whitby D (2011) Update on KSHV-Epidemiology, Kaposi sarcoma pathogenesis, and treatment of Kaposi sarcoma, Cancer Lett, June 28; 305(2): 150-162
23. Rosen S, Fox M, Gill C (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: A systematic review. PLoS Med, 4(10): e298. doi:10. 1371/journal.pmed.0040298.
24. Brinkhof M, Pujades-Rodriguez M, Egger M (2009) Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE, 4(6): e5790. doi:10.1371/journal.pone.0005790.
25. Brinkhof M, Spycher B, Yiannoutsos C, Weigel R, Wood R, et al. (2011) Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa. PLoS ONE, 5(11): e14149. doi:10.1371/journal.pone.0014149.
26. Stebbing J, Sanitt A, Nelson M, Powles T, Gazzard B, et al. (2006) A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy, Lancet; 367: 1495-502.
27. Sissolak G, Mayaud P (2005) AIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa, Tropical medicine and International Health, vol. 10 (10), 981-992. (Pubitemid 41445062)
28. Chu K, Misinde D, Massaquoic M, Pasulanic O, Mwagomba B (2010) Risk factors for mortality in AIDS-associated Kaposi sarcoma in a primary care antiretroviral treatment program in Malawi, International Health, 99-102.
29. Chu KM, Mahlangeni G, Swannet S, Nathan P, Boulle A, et al. (2010) AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa, Journal of the International AIDS Society, 13:23.
30. Krown S (2011) Treatment strategies for Kaposi's sarcoma in Sub- Saharan Africa: Challenges and opportunities, Current Opinion in Oncology, vol 23 (5), 463-468.
31. Iver L, Kendrick D, Doucette K (2005) Efficacy of antiretroviral therapy programs in resource-poor settings: A meta-analysis of the published literature, Clinical Infectious Diseases; 41:217-24. (Pubitemid 40962502)
32. Mosam A, Shaik F, Uldrick T, Esterhuizen T, Friedland G, et al. (2012) A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa, J Acquir Immune Defic. Syndr, Vol. 60: 150-157.